US Stock MarketDetailed Quotes

CYCC Cyclacel Pharmaceuticals

Watchlist
  • 0.3473
  • -0.0240-6.46%
Close Nov 21 16:00 ET
  • 0.3401
  • -0.0072-2.07%
Post 20:01 ET
2.18MMarket Cap-12P/E (TTM)

Cyclacel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-49.83%2.98M
-40.97%6M
-75.53%2.8M
-81.59%3.38M
-81.59%3.38M
-74.93%5.94M
-65.04%10.16M
-61.42%11.44M
-49.82%18.35M
-49.82%18.35M
-Cash and cash equivalents
-49.83%2.98M
-40.97%6M
-75.53%2.8M
-81.59%3.38M
-81.59%3.38M
-74.93%5.94M
-65.04%10.16M
-61.42%11.44M
-49.82%18.35M
-49.82%18.35M
Receivables
-49.61%1.62M
-52.21%1.41M
-75.92%1.67M
-33.95%3.73M
-33.95%3.73M
-20.30%3.22M
47.20%2.94M
46.75%6.94M
31.04%5.64M
31.04%5.64M
-Taxes receivable
-49.61%1.62M
-52.21%1.41M
-75.92%1.67M
-33.95%3.73M
-33.95%3.73M
-20.30%3.22M
47.20%2.94M
46.75%6.94M
31.04%5.64M
31.04%5.64M
Other current assets
-84.15%309K
-86.28%300K
-38.66%365K
-19.95%341K
-19.95%341K
1,047.06%1.95M
2,667.09%2.19M
-61.34%595K
439.24%426K
439.24%426K
Total current assets
-55.79%4.91M
-49.61%7.71M
-74.52%4.84M
-69.51%7.44M
-69.51%7.44M
-60.19%11.11M
-52.32%15.29M
-48.13%18.97M
-40.38%24.41M
-40.38%24.41M
Non current assets
Net PPE
-56.00%55K
-52.70%70K
-49.41%86K
-41.38%102K
-41.38%102K
-34.21%125K
-29.19%148K
136.11%170K
85.11%174K
85.11%174K
-Gross PPE
-56.00%55K
-52.70%70K
-49.41%86K
-6.28%522K
-6.28%522K
-34.21%125K
-29.19%148K
136.11%170K
22.42%557K
22.42%557K
-Accumulated depreciation
----
----
----
-9.66%-420K
-9.66%-420K
----
----
----
-6.09%-383K
-6.09%-383K
Non current prepaid assets
-67.20%413K
-58.70%413K
-57.34%1.24M
-63.67%1.26M
-63.67%1.26M
-56.82%1.26M
-67.32%1M
-2.15%2.92M
65.00%3.47M
65.00%3.47M
Total non current assets
-66.18%468K
-57.93%483K
-56.90%1.33M
-62.60%1.36M
-62.60%1.36M
-55.44%1.38M
-64.88%1.15M
1.11%3.09M
65.86%3.64M
65.86%3.64M
Total assets
-56.94%5.38M
-50.19%8.19M
-72.05%6.17M
-68.61%8.81M
-68.61%8.81M
-59.71%12.5M
-53.48%16.44M
-44.33%22.06M
-34.97%28.05M
-34.97%28.05M
Liabilities
Current liabilities
Payables
162.64%4.13M
118.58%4.74M
107.25%5.2M
38.34%3.54M
38.34%3.54M
59.82%1.57M
-1.63%2.17M
-11.96%2.51M
20.97%2.56M
20.97%2.56M
-accounts payable
162.64%4.13M
118.58%4.74M
107.25%5.2M
38.34%3.54M
38.34%3.54M
59.82%1.57M
-1.63%2.17M
-11.96%2.51M
20.97%2.56M
20.97%2.56M
Current accrued expenses
-69.57%1.89M
-52.80%2.05M
-38.04%2.85M
7.45%4.24M
7.45%4.24M
94.53%6.22M
91.91%4.34M
42.34%4.61M
55.09%3.94M
55.09%3.94M
Other current liabilities
-6.74%332K
68.80%395K
32.74%296K
-62.23%380K
-62.23%380K
106.98%356K
-58.06%234K
88.98%223K
33.60%1.01M
33.60%1.01M
Current liabilities
-22.05%6.35M
6.52%7.19M
13.79%8.35M
8.65%8.16M
8.65%8.16M
87.18%8.15M
34.22%6.75M
18.28%7.34M
38.76%7.51M
38.76%7.51M
Non current liabilities
Long term debt and capital lease obligation
--0
-92.42%5K
-73.75%21K
-65.09%37K
-65.09%37K
-51.40%52K
-41.59%66K
433.33%80K
253.33%106K
253.33%106K
-Long term capital lease obligation
--0
-92.42%5K
-73.75%21K
-65.09%37K
-65.09%37K
-51.40%52K
-41.59%66K
433.33%80K
253.33%106K
253.33%106K
Total non current liabilities
--0
-92.42%5K
-73.75%21K
-65.09%37K
-65.09%37K
-51.40%52K
-41.59%66K
433.33%80K
253.33%106K
253.33%106K
Total liabilities
-22.55%6.35M
5.56%7.19M
12.85%8.37M
7.63%8.2M
7.63%8.2M
83.86%8.2M
32.55%6.81M
19.28%7.42M
39.94%7.62M
39.94%7.62M
Shareholders'equity
Share capital
-83.33%2K
-99.96%2K
-99.98%1K
-99.98%1K
-99.98%1K
-99.73%12K
40,836.36%4.5M
44,930.00%4.5M
44,850.00%4.5M
44,850.00%4.5M
-common stock
-83.33%2K
-99.96%2K
-99.98%1K
-99.98%1K
-99.98%1K
-99.73%12K
40,836.36%4.5M
44,930.00%4.5M
44,850.00%4.5M
44,850.00%4.5M
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-3.18%-436.44M
-4.09%-434.49M
-4.68%-431.23M
-5.56%-428.28M
-5.56%-428.28M
-6.09%-423.01M
-6.04%-417.41M
-5.88%-411.96M
-5.51%-405.73M
-5.51%-405.73M
Paid-in capital
1.88%436.5M
3.01%436.4M
1.56%429.92M
1.61%429.8M
1.61%429.8M
1.40%428.46M
-0.35%423.63M
0.01%423.32M
0.00%422.98M
0.00%422.98M
Gains losses not affecting retained earnings
11.56%-1.03M
16.59%-915K
26.63%-898K
31.00%-908K
31.00%-908K
33.10%-1.17M
14.03%-1.1M
-48.72%-1.22M
-75.94%-1.32M
-75.94%-1.32M
Total stockholders'equity
-122.57%-970K
-89.63%999K
-115.07%-2.21M
-97.03%607K
-97.03%607K
-83.82%4.3M
-68.12%9.63M
-56.17%14.64M
-45.79%20.43M
-45.79%20.43M
Total equity
-122.57%-970K
-89.63%999K
-115.07%-2.21M
-97.03%607K
-97.03%607K
-83.82%4.3M
-68.12%9.63M
-56.17%14.64M
-45.79%20.43M
-45.79%20.43M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -49.83%2.98M-40.97%6M-75.53%2.8M-81.59%3.38M-81.59%3.38M-74.93%5.94M-65.04%10.16M-61.42%11.44M-49.82%18.35M-49.82%18.35M
-Cash and cash equivalents -49.83%2.98M-40.97%6M-75.53%2.8M-81.59%3.38M-81.59%3.38M-74.93%5.94M-65.04%10.16M-61.42%11.44M-49.82%18.35M-49.82%18.35M
Receivables -49.61%1.62M-52.21%1.41M-75.92%1.67M-33.95%3.73M-33.95%3.73M-20.30%3.22M47.20%2.94M46.75%6.94M31.04%5.64M31.04%5.64M
-Taxes receivable -49.61%1.62M-52.21%1.41M-75.92%1.67M-33.95%3.73M-33.95%3.73M-20.30%3.22M47.20%2.94M46.75%6.94M31.04%5.64M31.04%5.64M
Other current assets -84.15%309K-86.28%300K-38.66%365K-19.95%341K-19.95%341K1,047.06%1.95M2,667.09%2.19M-61.34%595K439.24%426K439.24%426K
Total current assets -55.79%4.91M-49.61%7.71M-74.52%4.84M-69.51%7.44M-69.51%7.44M-60.19%11.11M-52.32%15.29M-48.13%18.97M-40.38%24.41M-40.38%24.41M
Non current assets
Net PPE -56.00%55K-52.70%70K-49.41%86K-41.38%102K-41.38%102K-34.21%125K-29.19%148K136.11%170K85.11%174K85.11%174K
-Gross PPE -56.00%55K-52.70%70K-49.41%86K-6.28%522K-6.28%522K-34.21%125K-29.19%148K136.11%170K22.42%557K22.42%557K
-Accumulated depreciation -------------9.66%-420K-9.66%-420K-------------6.09%-383K-6.09%-383K
Non current prepaid assets -67.20%413K-58.70%413K-57.34%1.24M-63.67%1.26M-63.67%1.26M-56.82%1.26M-67.32%1M-2.15%2.92M65.00%3.47M65.00%3.47M
Total non current assets -66.18%468K-57.93%483K-56.90%1.33M-62.60%1.36M-62.60%1.36M-55.44%1.38M-64.88%1.15M1.11%3.09M65.86%3.64M65.86%3.64M
Total assets -56.94%5.38M-50.19%8.19M-72.05%6.17M-68.61%8.81M-68.61%8.81M-59.71%12.5M-53.48%16.44M-44.33%22.06M-34.97%28.05M-34.97%28.05M
Liabilities
Current liabilities
Payables 162.64%4.13M118.58%4.74M107.25%5.2M38.34%3.54M38.34%3.54M59.82%1.57M-1.63%2.17M-11.96%2.51M20.97%2.56M20.97%2.56M
-accounts payable 162.64%4.13M118.58%4.74M107.25%5.2M38.34%3.54M38.34%3.54M59.82%1.57M-1.63%2.17M-11.96%2.51M20.97%2.56M20.97%2.56M
Current accrued expenses -69.57%1.89M-52.80%2.05M-38.04%2.85M7.45%4.24M7.45%4.24M94.53%6.22M91.91%4.34M42.34%4.61M55.09%3.94M55.09%3.94M
Other current liabilities -6.74%332K68.80%395K32.74%296K-62.23%380K-62.23%380K106.98%356K-58.06%234K88.98%223K33.60%1.01M33.60%1.01M
Current liabilities -22.05%6.35M6.52%7.19M13.79%8.35M8.65%8.16M8.65%8.16M87.18%8.15M34.22%6.75M18.28%7.34M38.76%7.51M38.76%7.51M
Non current liabilities
Long term debt and capital lease obligation --0-92.42%5K-73.75%21K-65.09%37K-65.09%37K-51.40%52K-41.59%66K433.33%80K253.33%106K253.33%106K
-Long term capital lease obligation --0-92.42%5K-73.75%21K-65.09%37K-65.09%37K-51.40%52K-41.59%66K433.33%80K253.33%106K253.33%106K
Total non current liabilities --0-92.42%5K-73.75%21K-65.09%37K-65.09%37K-51.40%52K-41.59%66K433.33%80K253.33%106K253.33%106K
Total liabilities -22.55%6.35M5.56%7.19M12.85%8.37M7.63%8.2M7.63%8.2M83.86%8.2M32.55%6.81M19.28%7.42M39.94%7.62M39.94%7.62M
Shareholders'equity
Share capital -83.33%2K-99.96%2K-99.98%1K-99.98%1K-99.98%1K-99.73%12K40,836.36%4.5M44,930.00%4.5M44,850.00%4.5M44,850.00%4.5M
-common stock -83.33%2K-99.96%2K-99.98%1K-99.98%1K-99.98%1K-99.73%12K40,836.36%4.5M44,930.00%4.5M44,850.00%4.5M44,850.00%4.5M
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -3.18%-436.44M-4.09%-434.49M-4.68%-431.23M-5.56%-428.28M-5.56%-428.28M-6.09%-423.01M-6.04%-417.41M-5.88%-411.96M-5.51%-405.73M-5.51%-405.73M
Paid-in capital 1.88%436.5M3.01%436.4M1.56%429.92M1.61%429.8M1.61%429.8M1.40%428.46M-0.35%423.63M0.01%423.32M0.00%422.98M0.00%422.98M
Gains losses not affecting retained earnings 11.56%-1.03M16.59%-915K26.63%-898K31.00%-908K31.00%-908K33.10%-1.17M14.03%-1.1M-48.72%-1.22M-75.94%-1.32M-75.94%-1.32M
Total stockholders'equity -122.57%-970K-89.63%999K-115.07%-2.21M-97.03%607K-97.03%607K-83.82%4.3M-68.12%9.63M-56.17%14.64M-45.79%20.43M-45.79%20.43M
Total equity -122.57%-970K-89.63%999K-115.07%-2.21M-97.03%607K-97.03%607K-83.82%4.3M-68.12%9.63M-56.17%14.64M-45.79%20.43M-45.79%20.43M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data